CLINICAL_TRIALS
trial_result
· 2016-06-13
Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis [Phase 2]
Summary
Reports the completion of a Phase 2 efficacy and safety trial of R935788 tablets for rheumatoid arthritis, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigel Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-06-13